| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/06/2008 | EP1005274B1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
| 08/06/2008 | EP0778778B2 Probiotic compositions |
| 08/06/2008 | CN101238222A Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus |
| 08/06/2008 | CN101238132A Spirochromanone derivatives as acetyl coenzyme A carboxylase(ACC) inhibitors |
| 08/06/2008 | CN101238128A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 08/06/2008 | CN101238123A Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
| 08/06/2008 | CN101238117A Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 08/06/2008 | CN101238112A Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| 08/06/2008 | CN101238099A Salts of vildagliptin |
| 08/06/2008 | CN101237886A Compositions for affecting weight loss |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237870A Concomitant pharmaceutical agents and use thereof |
| 08/06/2008 | CN101237866A Use of thiazole derivatives and analogues in the treatment of cancer |
| 08/06/2008 | CN101237865A Methods of treatment utilizing certain melatonin derivatives |
| 08/06/2008 | CN101235061A Novel alpha-amylase inhibitor alcaftadine series compounds and application thereof |
| 08/06/2008 | CN101235016A Method for synthesizing fat-reducing medicament rimonabant |
| 08/06/2008 | CN101234992A Method for preparing aspartic acid |
| 08/06/2008 | CN101234194A Biological information medical insurance medicine for recovering sex function carbohydrate metabolism function and preparation technique |
| 08/06/2008 | CN101234171A Health product with blood fat lowering and preventing and treating cardio-cerebralvascular disease function and preparation thereof |
| 08/06/2008 | CN101234160A Fat-reducing and liver-protecting Chinese medicine preparation and preparation thereof |
| 08/06/2008 | CN101234156A Saururus loureiri extract and preparation technique thereof |
| 08/06/2008 | CN101234142A Mulberry series health care functional beverage for auxiliary reduction of blood sugar |
| 08/06/2008 | CN101234136A Medicament for curing diabetes retina affection |
| 08/06/2008 | CN101234106A Use of imidazolone compounds for treating cardiovascular and cerebrovascular diseases |
| 08/06/2008 | CN101234105A Pharmaceutical composition containing diabetosan and vildagliptin and preparation thereof |
| 08/06/2008 | CN101234104A Pharmaceutical composition containing lipoic acid and mecobalamin and preparation thereof |
| 08/06/2008 | CN101234101A Medicine for preventing and/or treating obesity |
| 08/06/2008 | CN101233885A Health tea |
| 08/06/2008 | CN101233884A Method for preparing bead type gynostemma pentaphylla health-care tea |
| 08/06/2008 | CN101233883A Method for preparing bead type gynostemma pentaphylla tea |
| 08/06/2008 | CN100408592C Fractionation of phytosterol esters in oil |
| 08/06/2008 | CN100408579C Xanthine derivative, production and use thereof as a medicament |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408098C Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 08/06/2008 | CN100408096C Gastrin compositions and methods of use and preparation |
| 08/06/2008 | CN100408093C Use of inhibitor of angiotonin converzyme in preparing pharmaceutical formulations for prevention of stroke, diabetes and/or congestive heart failure |
| 08/06/2008 | CN100408066C Preparing process and product of Chinese medicine dripping pill with tea extract |
| 08/06/2008 | CN100408054C Method for extracting alpha- glucosidase inhibitor from traditional Chinese cinnamomum cassia |
| 08/06/2008 | CN100408047C Medicinal composition of fructose diphosphate sodium and magnesium salt |
| 08/06/2008 | CN100408035C Use of valsartan or its metabolite to inhibit platelet aggregation |
| 08/06/2008 | CN100408031C Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| 08/06/2008 | CN100407948C A Chinese wolfberry cake and preparation process thereof |
| 08/05/2008 | US7408064 Neuropeptide y5 antagonist; therapy for eating disorders |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407978 For lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels; useful for therapy of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 08/05/2008 | US7407954 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/05/2008 | US7407943 Comprises oligonucleotide which targets apolipoprotein nucleotide sequences and prevents expression; gene expresion inhibition; diagnosis and treatment of cardiovascular, infectious, hyperlipidemic and atherosclerotic disorders |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407772 Screening and selection methods for statin drug combinations |
| 08/05/2008 | US7407676 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 08/05/2008 | CA2505968C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 08/05/2008 | CA2426632C Atorvastatin hemi-calcium form vii |
| 08/05/2008 | CA2392903C Trans olefinic glucokinase activators |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/05/2008 | CA2290622C Selective thyroid hormone analogs |
| 08/05/2008 | CA2286482C Nkt cell-activating agents containing .alpha.-glycosylceramides |
| 08/05/2008 | CA2223595C Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 07/31/2008 | WO2008092091A2 Mao inhibiting n-benzyl-n-propargyl-amines useful for treating obesity |
| 07/31/2008 | WO2008091624A2 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 07/31/2008 | WO2008090999A1 Glucosidase inhibitor |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090631A1 Fucoidan-derived oligosaccharide |
| 07/31/2008 | WO2008090534A1 Methods and compositions for inhibition of excessive weight gain, reduction of inappropriate eating behaviours and inhibition of binge eating for the treatment of obesity |
| 07/31/2008 | WO2008089984A2 Process for the preparation of ezetimibe and derivatives thereof |
| 07/31/2008 | WO2008089892A1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals |
| 07/31/2008 | WO2008089776A1 Formulation of and method for producing an infusion rehydration solution |
| 07/31/2008 | WO2008089669A1 A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 07/31/2008 | WO2008089636A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 07/31/2008 | WO2008089581A1 Fused aromatic ptp-1b inhibitors |
| 07/31/2008 | WO2008089580A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/31/2008 | WO2008089557A1 Atorvastatin calcium propylene glycol solvates |
| 07/31/2008 | WO2008089521A1 Insulin sensitisers and methods of treatment |
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008067084A3 Methods for reducing phosphate absorption |
| 07/31/2008 | WO2008063232A3 Substituted pyrazolopyrimidines |
| 07/31/2008 | WO2008026078A3 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182902 Sphingolipids in Treatment and Prevention of Steatosis and of Steatosis or of Hepatotoxicity and its Sequelae |
| 07/31/2008 | US20080182898 Treatment of metabolic syndrome with norfluoxetine |
| 07/31/2008 | US20080182896 Use of metal chelates in human or animal feeding |
| 07/31/2008 | US20080182891 Chromane and chromene derivatives and uses thereof |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182879 e.g. 6-hydroxy-2-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]chromone; tyrosine kinase inhibitors, anticarcinogenic and antiinflammatory agent; cerebral, genito-urinary tract, lymphatic system, stomach, laryngeal, pancreatic, breast or lung tumor; rheumatoid arthritis, psoriasis, contact dermatitis |
| 07/31/2008 | US20080182873 Process for the manufacture of hmg-coa reductase inhibitors |
| 07/31/2008 | US20080182861 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |